When should I see a doctor about hair thinning during perimenopause?

Hair thinning is one of the most distressing symptoms of perimenopause, and it is also one of the most undertreated because many women assume it is simply part of aging and that nothing can be done. This assumption is frequently wrong. Several treatable conditions contribute to hair thinning in perimenopausal women, and seeking evaluation earlier produces meaningfully better outcomes than waiting.

Gradual diffuse thinning across the scalp, widening of the part line, and reduced hair density over months to years are consistent with hormonal hair loss, technically called female pattern hair loss or androgenetic alopecia. This pattern is driven by the shift in the estrogen-to-androgen ratio that occurs during perimenopause and is the most common cause of hair thinning in this age group. It is not dangerous, but it is progressive without intervention.

Seek evaluation if hair loss is occurring in patches rather than diffusely, if you can clearly see areas of scalp through your hair that were previously covered, if loss is happening rapidly over weeks rather than slowly over months, if the scalp is itchy, scaly, or inflamed in the thinning areas, or if hair loss is accompanied by other symptoms suggesting a systemic cause.

Thyroid dysfunction is the most important condition to evaluate first. Both hypothyroidism and hyperthyroidism cause hair thinning, and thyroid disorders are significantly more common in perimenopausal women. A TSH and free T4 test are the appropriate starting point and are quick to obtain.

Ferritin, the stored form of iron, is the second most important test. Iron deficiency causes excessive shedding (telogen effluvium) even when hemoglobin is still in the normal range. Many laboratories use reference ranges that do not reflect the level at which iron deficiency affects hair. A ferritin below 30 to 50 micrograms per litre is associated with hair shedding even without full anemia, and correction often produces visible improvement in shedding within 3 to 6 months.

Nutritional factors that affect hair growth cycles include zinc, biotin, vitamin D, and adequate protein intake. Vitamin D deficiency is extremely common in perimenopausal women in northern latitudes and contributes to diffuse thinning. These can be assessed alongside thyroid and iron panels in a single blood draw.

Other conditions to consider include PCOS (polycystic ovary syndrome), which can persist into perimenopause and accelerate androgen-driven hair loss. Alopecia areata, an autoimmune patchy hair loss, requires dermatological evaluation and is distinct from hormonal thinning. Scalp conditions including seborrheic dermatitis and psoriasis can contribute to shedding if left untreated.

Topical minoxidil at 2 or 5 percent is the best-evidenced non-prescription treatment for female pattern hair loss and is FDA-cleared for this use. Consistent use over at least 6 months is needed to assess its effect. Prescription options include anti-androgens like spironolactone. Some evidence supports low-level laser therapy. Hormone therapy may slow the progression of androgenetic alopecia in perimenopausal women.

Tracking your symptoms with an app like PeriPlan can help you document the timeline of hair changes, correlate them with other symptoms or life events, and bring clear information to your medical appointment.

Prepare for your appointment by noting when shedding started, whether it has been gradual or sudden, whether the scalp is affected, any other symptoms alongside hair changes, and what you have already tried. Bringing a photo from before the thinning began can help your provider compare.

Scalp care during perimenopause includes being gentle with fragile hair. Avoiding tight hairstyles that create traction at the scalp, reducing heat styling frequency, using a wide-tooth comb on wet hair rather than a brush, and switching to a sulfate-free shampoo all reduce mechanical and chemical stresses on thinning hair. These do not regrow hair, but they reduce the rate of additional loss from external damage.

Nutritional adequacy is worth assessing alongside the hormonal picture. Iron, ferritin, zinc, vitamin D, and protein are all essential for hair cycle maintenance and are commonly suboptimal in perimenopausal women. Testing before supplementing is more useful than guessing, since some of these can be harmful at high doses. A dietitian or nutritionist familiar with perimenopausal health can help optimize nutrition for hair and overall wellbeing.

Minoxidil, available without prescription in topical formulations, is the most consistently effective topical treatment for androgenetic alopecia in women and can be used alongside hormonal approaches. It requires consistent long-term use to maintain any improvement achieved. Low-level laser therapy devices have modest evidence for stimulating hair growth. Platelet-rich plasma injections are used by some dermatologists with emerging evidence. A dermatologist who specializes in hair loss can discuss which combination of approaches is most appropriate for your specific hair loss pattern.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.